We have previously reported that activation of KCa3.1 channels by 1-EBIO or NS309 restored KCa3.1 function in HNSCC CD8+ T cells and abrogated the inhibitory effect of adenosine (Chimote et al., 2018). The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.